CTOs on the Move

Bardy Diagnostics

www.bardydx.com

 
Bardy Diagnostics, Inc. (bardydx.com) has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM™ can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Developed on the principle that non-invasive cardiac monitoring should provide an excellent quality atrial signal, the CAM is designed to be placed along the sternum—over the heart— to optimize P-wave signal capture. The result is improved ECG resolution, providing more information about the heart ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.bardydx.com
  • 316 Occidental Avenue South Suite B310
    Seattle, WA USA 98104
  • Phone: 844.777.9283

Executives

Name Title Contact Details
Ed Vertatschitsch
 Chief Operating Officer Profile

Funding

Bardy Diagnostics raised $35.5M on 04/16/2019

Similar Companies

The Female Health Company

The Female Health Company is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mirabilis Medica

Mirabilis Medica is a Bothell, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TriVascular

TriVascular has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular aortic repair (EVAR). TriVascular`s initial product offerings are novel endovascular grafts focused on significantly advancing EVAR. Building upon partnerships with thought leading clinicians worldwide, TriVascular`s products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR.

Novadaq

Enabling surgeons with clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing health care costs, is Novadaq’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to harmful ionizing radiation or contrast dye toxicity. More than 130 peer-reviewed publications demonstrate that the use of SPY during complex surgery, leads to fewer post-operative complications and lower hospital costs. The SPY Imaging System is United States Food and Drug Administration (“FDA”) 510(k) cleared for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT®, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. Our unique business model of partnering with market-leading companies to drive adoption of our fluorescence imaging technology, while building our own commercial infrastructure is the cornerstone of our corporate strategy for growth.

Omega Medical Laboratories

Omega Medical Laboratories is a Reading, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.